healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.
I woke up at 3:30 this morning because I slept half the day yesterday after arriving on a red-eye from HIMSS12 in Las Vegas. We were thrilled that the Annual Conference had record-breaking numbers of attendees and exhibitors. It was a fabulous week of learning and catching up with friends, and I was ready to [...]
Over the past several years, we have seen segmentation of EHR product offerings, usually tailored for different clinical settings. In a domain such as Radiology, the specialty requires integration of PACS into the EHR. However, in certain specialties such as oncology, the federal government, professional organizations, and even patient advocacy groups have recommended that the [...]
While just about every CIO in healthcare can be described as intelligent, only a handful deserve to be called wise. One of those is undoubtedly M. D. Anderson Cancer Center’s Lynn Vogel. And Vogel is not the kind of CIO to keep all that wisdom to himself. As such, he’s an active educator in both [...]
PODCAST: One-on-One w/University of Texas M. D. Anderson Cancer Center VP & CIO Lynn Vogel, Chapter 5 [ 11:31 ] Play Now | Play in Popup | Download (211)
The FDA has been receiving a great deal of criticism from the clinical community about a variety of issues, but probably none is as contentious as the ongoing patient safety issues regarding harmful drug-drug interactions and drug-gene interactions, estimated by the Institute of Medicine to cause 250,000 deaths each year in the U.S. The current [...]
It’s not just genomic scientists that are dealing with enormous amounts of DNA sequence data – the clinician will soon be next. However, the explosion in linking disease with genetics, and the realization that the FDA will require gene testing prior to the prescription of potentially hundreds of drugs, will challenge the storage capacity required for [...]
Individualizing drug therapy based on pharmacogenomics (PGx) is considered by many academic researchers and clinical experts as the “next significant domain of clinical practice” (see the American College of Clinical Pharmacology’s very informative web-based tutorial, “The Future of Medicine: Pharmacogenomics”, http://user.accp1.org/index_new.html). Drugs that are currently recommended for PGx testing by the FDA include specific medications [...]
An HHS committee on Physician and Patient Education is developing new certification requirements for hospital physicians in genomics and pharmacogenomics. Most hospital physicians, unless your specialty is oncology or obstetrics, are not familiar with anything but diseases inherited as classical Mendelien traits. These new rules will require basic certification in both classical genetics and the [...]
PGx is an abbreviation for Pharmacogenomics or Pharmacogenetics. Although those “in the know”, in the large drug companies, now just call it “PG”. Today was the first day of the ‘5th Workshop: Regulatory Decision Making’, sponsored by the FDA and the DIA (Drug Information Association), held in Rockville, MD. The crowd was about 300 attendees, [...]
The Ignite Institute is a new non-profit institute based in the National Capital region. Ignite is one of the first entities to fully integrate biomedical research, development, commercialization, all integrated into a hospital and healthcare network. In November 2009, Virginia Governor Timothy Kaine announced a $200 million commitment from the State and its partners to [...]
Loading ...| Join Our Mailing List |
 |
|---|
Most Recent Comments